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Endothelial dysfunction and myocardial
injury after major emergency abdominal
surgery: a prospective cohort study
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Abstract
Background: Preoperative endothelial dysfunction is a predictor of myocardial injury and major adverse cardiac
events. Non-cardiac surgery is known to induce acute endothelial changes. The aim of this explorative cohort study
was to assess the extent of systemic endothelial dysfunction after major emergency abdominal surgery and the
potential association with postoperative myocardial injury.
Methods: Patients undergoing major emergency abdominal surgery were included in this prospective cohort
study. The primary outcome was the change in endothelial function expressed as the reactive hyperemia index
from 4-24 h after surgery until postoperative day 3–5. The reactive hyperemia index was assessed by non-invasive
digital pulse tonometry. Secondary outcomes included changes in biomarkers of nitric oxide metabolism and
bioavailability. All assessments were performed at the two separate time points in the postoperative period. Clinical
outcomes included myocardial injury within the third postoperative day and major adverse cardiovascular events
within 30 days of surgery.
Results: Between October 2016 and June 2017, 83 patients were included. The first assessment of the endothelial
function, 4–24 h, was performed 15.8 (SD 6.9) hours after surgery and the second assessment, postoperative day 3–
5, was performed 83.7 (SD 19.8) hours after surgery. The reactive hyperemia index was suppressed early after
surgery and did not increase significantly; 1.64 (95% CI 1.52–177) at 4–24 h after surgery vs. 1.75 (95% CI 1.63–1.89)
at postoperative day 3–5, p = 0.34. The L-arginine/ADMA ratio, expressing the nitric oxide production, was reduced
in the perioperative period and correlated significantly with the reactive hyperemia index. A total of 16 patients
(19.3%) had a major adverse cardiovascular event, of which 11 patients (13.3%) had myocardial injury. The L-
arginine/ADMA ratio was significantly decreased at 4–24 h after surgery in patients suffering myocardial injury.
Conclusion: This explorative pathophysiological study showed that acute systemic endothelial dysfunction was
present early after major emergency abdominal surgery and remained unchanged until day 3–5 after the
procedure. Early postoperative disturbances in the nitric oxide bioavailability might add to the pathogenesis of
myocardial injury. This pathophysiological link should be confirmed in larger studies.
Trial registration: clinicaltrials.gov no. NCT03010969.
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Background
The endothelium is important in the regulation of vascu-
lar homeostasis, vascular tone and influences the systemic
coagulability and inflammation [1–3]. The function of the
endothelial cells is affected by inflammatory and oxidative
changes in the cellular environment, which can induce
endothelial dysfunction [1]. Nitric oxide (NO) is an essen-
tial endothelium-derived vasodilatory substance primarily
produced by the endothelial NO synthase. Endothelial
dysfunction is largely characterized by an impaired
endothelium-dependent vasodilation [4]. The function of
the endothelium can be assessed by non-invasive digital
pulse tonometry with which the nitric oxide dependent
vasodilator function of the microcirculation is digitally
assessed [5]. The presence of endothelial dysfunction has
been associated with an increased risk of developing car-
diovascular diseases [6] and the assessment of endothelial
function prior to surgery might improve the risk stratifica-
tion for postoperative myocardial injury and major adverse
cardiac events [7]. The surgical trauma induces systemic
and local inflammation, oxidative stress and changes in
neuro-humoral activity [8]. Postoperative endothelial dys-
function might therefore be a consequence of the surgical
stress response. The aim of this explorative prospective
cohort study was to examine the early acute endothelial
dysfunction and NO bioavailability after major emergency
abdominal surgery, and study the potential association be-
tween endothelial function and postoperative myocardial
injury and major adverse cardiovascular events.
Methods
Study design, setting and participants
All included patients gave their oral and written informed
consent. The study was approved by the Regional Ethics
Committee in Region Zealand (SJ-527) and the Danish
Data Protection Agency (REG-20-2016). The study was
registered with clinicaltrials.gov (No. NCT03010969) and
reported according to the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) State-
ment. The study was an explorative prospective cohort
study including patients undergoing major emergency ab-
dominal surgery in the Department of Surgery, Zealand
University Hospital, Denmark. Eligible patients were
screened and included within 4–24 h of the emergent sur-
gical procedure between October 2016 and June 2017. Eli-
gible patients were adults (≥18 years) that underwent
emergency surgery within 72 h of the admission to the De-
partment of Surgery or an emergency reoperation. Surgical
procedures included open, laparoscopic, or laparoscopic-
ally assisted procedures involving the stomach, small or
large bowel, or rectum for conditions such as perforation,
ischemia, abdominal abscess, bleeding or obstruction,
washout/evacuation of intra-peritoneal hematoma or ab-
scess, laparotomy/laparoscopy with inoperable pathology
(e.g. peritoneal/hepatic metastases), adhesiolysis, fascial de-
hiscence or any reoperation meeting the criteria above. Pa-
tients were excluded if transferred directly from the
operating room or the post-anesthesia care room to the in-
tensive care unit. The study protocol did not define clinical
criteria for immediate postoperative intensive care unit
transfer. The transfer was done at the discretion of the at-
tending anesthesiologist and surgeon. Research personnel
prospectively collected patient data from the electronic
medical records. During hospitalization, patients reported
directly to the research personnel. Patients were followed-
up for 30 days after surgery. Preoperative comorbidity and
performance were rated with the American Society of An-
esthesiologists physical status classification (ASA) [9], the
revised cardiac risk score [10] and the World Health
Organization performance status [11]. The attending
anesthetist decided on the anesthetic regime.
Outcomes
The primary outcome was the change in endothelial func-
tion, expressed as the reactive hyperemia index (RHI),
assessed by non-invasive digital pulse tonometry. The
endothelial function was assessed within 4–24 h of surgery
and repeated once again between postoperative day 3 and
5. Secondary outcomes included changes in biomarkers of
NO metabolism and bioavailability (plasma L-arginine,
plasma asymmetric dimethyl arginine (ADMA) and
plasma biopterins (dihydrobiopterin (BH2), tetrahydro-
biopterin (BH4), BH2 and biopterin metabolites). The NO
biomarkers were assessed in relation to each endothelial
function measurement with non-invasive digital pulse to-
nometry. Clinical outcomes at 30-days after surgery in-
cluded myocardial injury (peak plasma cardiac troponin
I ≥ 45 ng.l− 1 (99th percentile URL, 10% CV at 40 ng.l− 1))
and the composite major adverse cardiovascular events
(myocardial injury, acute coronary syndrome, congestive
heart failure, stroke, cardiovascular death or sudden unex-
pected death, non-fatal cardiac arrest, new clinically im-
portant cardiac arrhythmia and coronary revascularization
procedure). A clinically important cardiac arrhythmia was
defined as an event that led to a medical or procedural
intervention. Cardiac troponin-I was assessed daily in the
morning on postoperative day 1 to 3.
Data sources and measurements
The measurement of the endothelial function was per-
formed with an EndoPAT2000 (Itamar medical ltd, Israel).
The EndoPAT assessment, a non-invasive digital pulse to-
nometry, has been described elsewhere [12]. In short, the
digital pulse amplitude is assessed at rest and during react-
ive hyperemia. The assessment has three phases: baseline
(resting phase), occlusion and hyperemia. A finger-probe
was placed on each index finger. One serving as a control
in order to adjust for any systemic effects. The assessment
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was initiated with the baseline assessment of the finger
pulse amplitude (baseline phase). After 5min, a blood
pressure cuff on the upper arm was inflated to 200mmHg
(suprasystolic) and the blood flow to the forearm was
ceased (occlusion phase). After 5min of forearm ischemia,
the cuff was deflated and the finger-pulse amplitude was
automatically assessed for 5min during reperfusion of the
forearm (hyperemia phase). The endothelial function was
expressed as RHI, which was calculated automatically.
RHI is defined as the ratio between the finger-pulse ampli-
tude during hyperemia and rest (baseline) [13].
Blood was drawn into 4 ml EDTA tubes for analysis of
NO biomarkers. For analysis of L-arginine and ADMA,
blood samples were centrifuged for 10 min at 3000 g and
plasma was snap-frozen and stored at − 80 °C. Quantifi-
cation of L-arginine and ADMA was achieved by HPLC
with fluorescence detection as described by Schou-
Pedersen et al. [14] For analysis of biopterins, blood was
mixed with dithioerythritol and centrifuged at 2000 g for
5 min. Plasma was snap-frozen and stored at − 80 °C.
Biopterins were analyzed using HPLC with fluorescence
detection as described previously [15]. In order to reduce
the risk of bias, all experimental procedures were stan-
dardized and performed by trained research personnel
who was unfamiliar with the patients’ clinical condition.
Study size and statistics
The study was explorative; therefore, a predefined sample
size calculation was not performed. Instead, all patients
that presented for major emergency abdominal surgery
were consecutively screened and included from October
2016 to June 2017. The study was a predefined substudy
of the POETRY abdominal study that included patients
from October 2016 to November 2018 (clinicaltrials.gov
No. NCT03010969). Continuous data were expressed as
mean (standard deviation or 95% confidence interval) or
median (IQR) depending on data distribution. Histograms
and QQ-plots of residuals were performed to describe
data distribution and homogeneity of variances. The endo-
thelial function, expressed as RHI, and level of NO bio-
markers at 4–24 h vs. postoperative day 3–5 were
compared with a paired t-test. A mixed model was per-
formed to evaluate the change of RHI and NO biomarkers
stratified on the presence of myocardial injury or major
adverse cardiovascular events. An unstructured variance-
covariance structure was chosen since this model had the
smallest AIC values and − 2 Log Likelihood scores. The
correlations between RHI and L-arginine, ADMA and the
L-arginine/ADMA ratio were tested. The correlations
were expressed with scatter-plots and Pearson correlation
coefficients. Statistical analyses were considered significant
if the two-sided p-value < 0.05. All statistical analyses were
performed with SAS version 9.4 (SAS Institute A/S, U.S.).
Results
Study population and descriptive data
In total, 153 patients were consecutively screened for in-
clusion between October 2016 and June 2017. We ended
up including 83 patients in this study, Fig. 1. The mean
age was 64.1 (SD 15.8) years and 53% were male. The
majority of the patients had a performance score of 0–1
(95.2%) and was ASA I-II (62.7%). The most common
cardiovascular risk factors were hypertension (31.3%)
and ischemic heart disease (8.4%). Baseline patient char-
acteristics are available in Table 1. Total intravenous
anesthesia with propofol and remifentanil was the most
common anesthetic regime and 44.6% had a periopera-
tive epidural. All but six patients suffered peroperative
hypotension (systolic blood pressure < 100mmHg for >
5 min). The surgical procedures are specified in Table 2.
Sixteen out of 83 patients (19.3%) had a major adverse
cardiovascular event within 30 days of surgery, the most
common being myocardial injury (11/83 patients,
13.3%). Other than that, one patients had congestive
heart failure (1.2%), one patient had a non-fatal cardiac
arrest (1.2%), and four patients had a new clinically im-
portant cardiac arrhythmia (4.8%). In total, 29 out of 83
patients (34.9%) had a postoperative surgical complica-
tion (Clavien-Dindo ≥3) and 13 out of 83 patients
(15.7%) had sepsis within 30-days of surgery. Only two
patients (2.4%) had severe anemia defined as a b-
hemoglobin < 6.9 g∙dL− 1 within three days of surgery.
Median lengths of stay was 7.0 (q1-q3, 5.0–12.0) days.
Endothelial function and nitric oxide biomarkers
The first assessment of the endothelial function, 4–24 h,
was performed 15.8 (SD 6.9) hours after surgery and the
Fig. 1 Patients flowchart
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second assessment, postoperative day 3–5, was per-
formed 83.7 (SD 19.8) hours after surgery. RHI was 1.64
(95% CI 1.52–1.77) at 4–24 h after surgery and 1.75
(95% CI 1.63–1.89) at postoperative day 3–5, p = 0.34.
Four patients had a reoperation between the first and
second endothelial assessment. L-arginine and ADMA
both increased significantly in the postoperative period
resulting in an unchanged L-arginine/ADMA ratio. BH4
and the total biopterin level decreased significantly (p =
0.0008 and p = 0.0001, respectively), while BH2 and the
BH2/BH4 ratio remained stable, Table 3. Positive correla-
tions were found between RHI and L-arginine (Pearson
Table 1 Basic characteristics of patients undergoing major emergency abdominal surgery
Characteristics Whole cohort (n = 83)
Age; years 64.1 (15.8)
Male 44 (53.0%)
BMI 25.3 (5.4)
Smoking (no/former/active) 35 (42.1%)/32 (38.6%)/16(19.3%)
Alcohol (none, ≤ 7 units/week, > 7 units/week) 35 (42.2%)/27 (32.5%)/21 (25.3%)
Preoperative sBP/dBP; mmHg 140.3 (22.2)/78.9 (13.0)
Hemoglobin; g.dl−1 13.4 (2.7)
Leucocytes; × 109.l−1 12.6 (6.3)
CRP; mg.l−1 (median (IQR)) 11.0 (54.0)
Thrombocytes; × 109.l−1 283.6 (118.0)
Creatinine; mg.dl−1 0.93 (0.43)
Albumin; g.l−1 35.0 (6.9)
Cardiovascular risk factors
Ischemic heart disease 7 (8.4%)
Atrial fibrillation 5 (6.0%)
Hypertension 26 (31.3%)
Congestive heart failure 3 (3.6%)
Peripheral arterial disease 6 (7.2%)
Cerebrovascular disease 5 (6.0%)
Diabetes 6 (7.2%)
RCRI (1/2/≥3) 67 (80.7%)/13 (15.7%)/3 (3.6%)
ASA (1–2/3–4) 52 (62.7%)/31 (37.3%)
Performance score (0–1/2–3) 79 (95.2%)/4 (4.8%)
Preoperative medication
Acetylsalicylic acid 17 (20.5%)
Statin 14 (16.9%)
ADP-receptor inhibitors 9 (10.8%)
Anticoagulation 5 (6.0%)
Beta blockers 7 (8.4%)
Calcium channel blockers 9 (10.8%)
Diuretics 20 (24.1%)
ACE-I/ARBs 18 (21.7%)
Antidiabetics (per oral)/Insulin 4 (4.8%)/2 (2.4%)
Assessment of endothelial function, hrs. from end of operation
Assessment 1 (4–24 h) 15.8 (6.9)
Assessment 2 (POD3–5) 83.7 (19.8)
Data are expressed as mean (standard deviation) or frequencies (%) unless otherwise indicated
ACE-I angiotensin-converting-enzym inhibitor; ARBs angiotensin-receptor blocker; ASA American Society of Anesthesiologists Classification; BMI Body Mass Index;
CRP C-reactive protein; dBP diastolic blood pressure; POD postoperative day; RCRI Revised Cardiac Risk Index; sBP systolic blood pressure
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correlation coefficient 0.17, p = 0.048) and between RHI
and the L-arginine/ADMA ratio (Pearson correlation co-
efficient 0.18, p = 0.033), Fig. 2.
Cardiovascular events and endothelial function
An exploratory analysis on the difference between pa-
tients with and without myocardial injury was per-
formed, Fig. 3a-h. RHI did not differ between patients
with and without myocardial injury and RHI did not
change significantly over time in any of the groups, Fig.
3a. L-arginine and ADMA did not differ between pa-
tients with and without myocardial injury, but the L-
arginine/ADMA ratio was significantly suppressed at 4–
24 h after surgery in patients suffering myocardial injury,
Fig. 3b-d.
The biopterin levels did not differ between patients with
and without myocardial injury, Fig. 3e-h. No difference
was observed when RHI and NO biomarkers were strati-
fied on major adverse cardiovascular events, Table 4.
Discussion
In this explorative prospective cohort study on patients
undergoing major emergency abdominal surgery, the
endothelial function, expressed as the reactive hyperemia
index, and the NO-production, expressed as L-arginine/
ADMA ratio, remained reduced during the postoperative
period.
The endothelial function was severely suppressed,
however, whether this endothelial dysfunction was
present already before the surgical procedure is not
known. Other studies in the field do report of acute
changes in the endothelial function early after moderate-
major non-cardiac surgery with RHI of 1.47 (95% CI
1.08–1.98) [12] and 1.52 (± 0.28) [16] early after the pro-
cedure. Likewise, the NO production expressed as the L-
Table 2 Peroperative surgical and anesthetic characteristics
Whole cohort (n = 83)
Primary surgical procedure
Upper gastrointestinal surgery 7 (8.4%)
Small bowel resection 15 (18.1%)
Large bowel resection 10 (12.0%)
Laparotomy (no resection)* 39 (47.0%)
Combined small and large bowel resection 4 (4.8%)
Other 8 (9.6%)
Peritoneal contamination (none /serous/local contamination/diffuse contamination) 53 (63.9%)/9 (10.8%)/9 (10.8%)/12 (14.5%)
Duration of surgery; min (median (IQR)) 115.0 (72.5)
Duration of anesthesia; min (median (IQR)) 157.0 (88)
TIVA/volatile/combination 45 (54.2%)/29 (34.9%)/9 (10.8%)
Perioperative epidural 37 (44.6%)
Peroperative hypotension 77 (92.8%)
*surgical finding of e.g. adhesions, abdominal abscess, inoperable pathology
Values are frequencies (proportion) unless otherwise indicated
Peroperative hypotension was defined as > 5 min with systolic blood pressure < 100 mmHg
TIVA total intravenous anesthesia
Table 3 Reactive hyperemia index and nitric oxide bioavailability assessed at two time points after surgery
Assessment 1
4–24 h
Assessment 2
POD 3–5
p value
Reactive hyperemia index 1.64 (1.52–1.77) 1.75 (1.63–1.89) 0.34
L-arginine; μmol.l− 1 56.94 (52.45–61.43) 72.76 (67.62–77.91) < 0.0001
ADMA; μmol.l− 1 0.38 (0.34–0.41) 0.42 (0.39–0.46) 0.048
L-arginine/ADMA 158.46 (141.25–177.75) 175.59 (155.75–197.95) 0.097
BH4; nmol.l
− 1 7.90 (7.22–8.59) 6.47 (5.69–7.25) 0.0008
BH2; nmol.l
− 1 4.11 (3.67–4.61) 3.73 (3.41–4.07) 0.23
BH2/BH4 0.56 (0.48–0.65) 0.68 (0.55–0.83) 0.052
BH2 and biopterin metabolites; nmol.l
− 1 11.99 (11.08–12.96) 9.89 (9.06–10.78) 0.0001
ADMA asymmetric dimethyl arginine; BH4 tetrahydrobiopterin; BH2 dihydrobiopterin; POD postoperative day
Mean with 95% confidence interval. Paired t-tests were applied to compare the assessments
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arginine/ADMA ratio was reduced in our study early
after surgery. This pattern has been observed in other
surgical studies [12, 17] and is in line with the positive
correlation identified between RHI and the L-arginine/
ADMA ratio. Preoperatively, the patients in our study all
suffered from an acute illness and the extent of endothe-
lial dysfunction after the emergent surgical procedure
was likely the combined product of acute illness and
surgical stress.
Several clinical studies have reported of an association
between systemic endothelial function and the risk of
coronary disease and further cardiovascular morbidity
[6, 18]. Adding the preoperative RHI value to the Re-
vised Cardiac Risk Index has been shown to improve the
risk classification for postoperative myocardial injury,
which supports the pathophysiological role of endothe-
lial dysfunction in the development of myocardial injury
[7]. The L-arginine/ADMA ratio is an indirect biochem-
ical measure of the NO-production [4]. Interestingly, we
found that patients suffering myocardial injury had a sig-
nificantly lower L-arginine/ADMA ratio, thus a lower
NO-production than patients without myocardial injury
4–24 h after surgery. This finding might indicate a role
for lower perioperative NO bioavailability in the patho-
genesis of myocardial injury. This analysis was explora-
tive and should be confirmed in a larger study. We did
not find any difference in the L-arginine/ADMA ratio
between patients with and without major adverse cardio-
vascular events within 30 days of surgery.
In the vessels, NO is produced by the endothelial NO
synthase (eNOS) [19]. BH4 is a central eNOS cofactor
and a low plasma level of BH4 has been associated with
uncoupling of eNOS [19]. The uncoupling reduces the
NO production and increases systemic oxidative stress
since eNOS switches to produce reactive oxygen species
such as superoxide leading to the formation of peroxini-
trite [20]. In this study, BH4 decreased over time after
major emergency abdominal surgery. The level of BH4
depends on de novo synthesis, redox balance and biop-
terin clearance [19]. Systemic redox imbalance after sur-
gery may cause BH4 oxidation to BH2 and other
oxidized biopterin metabolites [21]. However, this mech-
anism does not explain that BH2 remained unchanged
and that biopterin metabolites decreased significantly.
An increased biopterin clearance combined with BH4
oxidation and a reduced de novo synthesis might in
combination explain the postoperative biopterin levels.
Interestingly, the BH2/BH4 ratio remained unchanged in
the postoperative period. Since binding of BH2 to eNOS
causes an uncoupling of the NO production, the BH2/
BH4 ratio has been argued to reflect the extent of eNOS
uncoupling and NO production [21–24]. In patients
undergoing major colon cancer surgery, the preoperative
BH2/BH4 ratio was 0.53 (95% CI 0.46–1.37) [12]. The
Fig. 2 Correlations between reactive hyperemia index and nitric
oxide biomarkers. A. The correlation between reactive hyperemia
index (RHI) and L-arginine. B. The correlation between RHI and
asymmetric dimethyl arginine (ADMA). C. The correlation between
RHI and the L-arginine/ADMA ratio. r = Pearson
correlation coefficient
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ratio is comparable to the postoperative ratio found in
this study, thus, the biopterin balance seems to be pre-
served at least until day 3–5 after major emergency ab-
dominal surgery.
Our study has a number of strengths and limitations.
The study was a prospective cohort study with prespeci-
fied methods and outcomes. The inclusion criteria were
wide in order to increase the generalizability of the
study; however, this did also result in a heterogenic
population with a large inter-patient variance. Besides
differences in the surgical stress response, patients suf-
fered from a variety of postoperative surgical and med-
ical complications including sepsis and pain, which
potentially could have affected the systemic endothelial
function. Patients transferred directly to the intensive
care unit from the operation room could not be included
Fig. 3 Changes in reactive hyperemia index and nitric oxide biomarkers stratified on the presence or absence of myocardial injury within the
third postoperative day. Abbreviations: ADMA, asymmetric dimethyl arginine; BH2, dihydrobiopterin; BH4, tetrahydrobiopterin; MINS, myocardial
injury; RHI, reactive hyperemia index
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in the study. Therefore, the results cannot be generalized
to this severely ill part of the surgical population and
only the patients with the best prognosis were repre-
sented. Criteria for intensive care unit transfer were not
defined in the study protocol but decided by the attend-
ing clinician. This could be a potential source of selec-
tion bias. No preoperative assessment of the endothelial
function was performed due to the acute setting of the
study. The endothelial function was assessed within 4–
24 h after surgery and on postoperative day 3–5. Such
time intervals have previously been used when assessing
the endothelial function after an acute event [25]. How-
ever, the large variance could add to the heterogeneity of
the study. The observational design prevents us from
commenting on causality. The systemic endothelial func-
tion assessed by non-invasive digital pulse tonometry
has previously been correlated with coronary micro-
vascular endothelial function assessed invasively during
coronary angiography [26]. A Non-invasive assessment
of the coronary microvascular function can be per-
formed with transthoracic Doppler echocardiography of
the left anterior descending coronary artery [27]. A non-
invasive assessment of the postoperative coronary micro-
vascular function could potentially have added interest-
ing data to our study of peripheral and systemic
endothelial function.
In conclusion, systemic endothelial dysfunction was
present in the perioperative period after major emer-
gency abdominal surgery and did not significantly
improve during the study period. The L-arginine/
ADMA ratio was reduced early after surgery in pa-
tients with myocardial injury, which might imply that
an impaired endothelial NO-production adds to the
pathogenesis of myocardial injury. This hypothesis-
generating finding should be confirmed in larger
cohort studies.
Table 4 Endothelial function in patients with and without major adverse cardiovascular events
Patients suffering major adverse cardiovascular
events (n = 16)
Patients without major adverse cardiovascular
events (n = 67)
p
value
Reactive hyperemia index 0.36
4–24 h 1.62 (1.33–1.96) 1.65 (1.52–1.80)
POD3–5 1.88 (1.64–2.16) 1.72 (1.58–1.89)
L-arginine; μmol.l− 1 0.96
4–24 h 49.54 (43.16–55.91) 58.73 (53.40–64.07)
POD3–5 65.66 (52.57–78.76) 74.64 (68.99–80.30)
ADMA; μmol.l− 1 0.24
4–24 h 0.43 (0.35–0.51) 0.37 (0.33–0.41)
POD3–5 0.44 (0.33–0.55) 0.42 (0.38–0.46)
L-arginine/ADMA 0.21
4–24 h 117.55 (95.21–145.15) 164.51 (145.79–185.62)
POD3–5 155.04 (112.88–212.96) 181.49 (159.16–206.95)
BH4; nmol.l
− 1 0.53
4–24 h 8.75 (6.99–10.52) 7.69 (6.94–8.44)
POD3–5 6.70 (5.47–7.92) 6.41 (5.48–7.35)
BH2; nmol.l
−1 0.92
4–24 h 4.85 (3.54–6.63) 3.95 (3.50–4.46)
POD3–5 4.46 (3.44–5.77) 3.57 (3.26–3.90)
BH2/BH4 0.88
4–24 h 0.59 (0.41–0.85) 0.56 (0.47–0.66)
POD3–5 0.70 (0.49–0.99) 0.67 (0.53–0.85)
BH2 and biopterin metabolites;
nmol.l− 1
0.97
4–24 h 13.74 (11.42–16.52) 11.59 (10.63–12.64)
POD3–5 11.22 (9.65–13.05) 9.58 (8.66–10.61)
ADMA asymmetric dimethyl arginine; BH4 tetrahydrobiopterin; BH2 dihydrobiopterin; POD postoperative day
Mean with 95% confidence interval. A mixed model was applied to evaluate the development over time stratified on major adverse cardiovascular events
Ekeloef et al. BMC Anesthesiology           (2020) 20:67 Page 8 of 9
Abbreviations
ADMA: Asymmetric dimethyl arginine; ASA: American Society of
Anesthesiologists physical status classification; BH2: Dihydrobiopterin;
BH4: Tetrahydrobiopterin; eNOS: Endothelial nitric oxide synthase; NO: Nitric
oxide; RHI: Reactive hyperemia index
Acknowledgements
Not applicable.
Authors’ contributions
SE was responsible for the concept and design of the study, the analysis and
interpretation of data and wrote the first draft of the manuscript. JOO and
AF contributed to the acquisition of data and critical revision of the
manuscript. JB, AMSP and JL contributed to the analysis and interpretation
of data as well as critical revision of the manuscript. IG contributed to the
concept and design of the study and critical revision of the manuscript. All
authors read and approved the final manuscript.
Funding
The study was funded by Region Zealand’s Research Foundation, grant no.
15–000342, and University of Copenhagen, grant no. 211–0480/13–3000. The
funding body had no influence on the design of the study and collection,
analysis, and interpretation of data or in writing the manuscript.
Availability of data and materials
The datasets used and/or analyzed during the current study are available
from the corresponding author on reasonable request.
Ethics approval and consent to participate
All included patients gave their oral and written informed consent. The study
was approved by the Ethics Committee (full name: Regional Ethics
Committee of Region Zealand, Denmark) (reference number SJ-527) to the
Department of Surgery, Zealand University Hospital, Denmark.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Center for Surgical Science, Department of Surgery, Zealand University
Hospital, Lykkebækvej 1, 4600 Koege, Denmark. 2Faculty of Health & Medical
Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark.
Received: 19 November 2019 Accepted: 2 March 2020
References
1. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis.
Circulation. 2004;109:Iii27–32.
2. Munzel T, Sinning C, Post F, Warnholtz A, Schulz E. Pathophysiology,
diagnosis and prognostic implications of endothelial dysfunction. Ann Med.
2008;40:180–96.
3. Cahill PA, Redmond EM. Vascular endothelium - gatekeeper of vessel health.
Atherosclerosis. 2016;248:97–109.
4. Bode-Boger SM, Scalera F, Ignarro LJ. The L-arginine paradox: importance of
the L-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ther. 2007;
114:295–306.
5. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P. Role of
nitric oxide in the regulation of digital pulse volume amplitude in humans.
J Appl Physiol (1985), 2006. 101:545–8.
6. Matsuzawa Y, Sugiyama S, Sumida H, Sugamura K, Nozaki T, Ohba K, et al.
Peripheral endothelial function and cardiovascular events in high-risk
patients. J Am Heart Assoc. 2013;2:e000426.
7. McIlroy DR, Chan MT, Wallace SK, Symons JA, Koo EG, Chu LC, et al.
Automated preoperative assessment of endothelial dysfunction and risk
stratification for perioperative myocardial injury in patients undergoing non-
cardiac surgery. Br J Anaesth. 2014;112:47–56.
8. Desborough JP. The stress response to trauma and surgery. Br J Anaesth.
2000;85:109–17.
9. Knuf KM, Maani CV, Cummings AK. Clinical agreement in the American
Society of Anesthesiologists physical status classification. Periop Med (Lond).
2018;7:14.
10. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective
validation of a simple index for prediction of cardiac risk of major
noncardiac surgery. Circulation. 1999;100:1043–9.
11. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the
eastern cooperative oncology group. Am J Clin Oncol. 1982;5:649–55.
12. Ekeloef S, Larsen MH, Schou-Pedersen AM, Lykkesfeldt J, Rosenberg J,
Gogenur I. Endothelial dysfunction in the early postoperative period after
major colon cancer surgery. Br J Anaesth. 2017;118:200–6.
13. McCrea CE, Skulas-Ray AC, Chow M, West SG. Test-retest reliability of pulse
amplitude tonometry measures of vascular endothelial function:
implications for clinical trial design. Vasc Med. 2012;17:29–36.
14. Schou-Pedersen AMV, Lykkesfeldt J. Comparison of three sample
preparation procedures for the quantification of L-arginine, asymmetric
Dimethylarginine, and symmetric Dimethylarginine in human plasma using
HPLC-FLD. J Anal Methods Chem. 2018;2018:6148515.
15. Reimann MJ, Haggstrom J, Mortensen A, Lykkesfeldt J, Moller JE, Falk T,
et al. Biopterin status in dogs with myxomatous mitral valve disease is
associated with disease severity and cardiovascular risk factors. J Vet Intern
Med. 2014;28:1520–6.
16. Ohno S, Kohjitani A, Miyata M, Tohya A, Yamashita K, Hashiguchi T, et al.
Recovery of endothelial function after minor-to-moderate surgery is
impaired by diabetes mellitus, obesity, Hyperuricemia and Sevoflurane-
based anesthesia. Int Heart J. 2018;59:559–65.
17. Ekeloef S, Godthaab C, Schou-Pedersen AMV, Lykkesfeldt J, Gogenur I. Peri-
operative endothelial dysfunction in patients undergoing minor abdominal
surgery: an observational study. Eur J Anaesthesiol. 2019;36:130–4.
18. Matsuzawa Y, Li J, Aoki T, et al. Predictive value of endothelial function by
noninvasive peripheral arterial tonometry for coronary artery disease. Coron
Artery Dis. 2015;26:231–8.
19. Bendall JK, Douglas G, McNeill E, Channon KM, Crabtree MJ.
Tetrahydrobiopterin in cardiovascular health and disease. Antioxid Redox
Signal. 2014;20:3040–77.
20. Zou MH, Shi C, Cohen RA. Oxidation of the zinc-thiolate complex and
uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin
Invest. 2002;109:817–26.
21. Joshi S, Kar S, Kavdia M. Computational analysis of interactions of oxidative
stress and tetrahydrobiopterin reveals instability in eNOS coupling.
Microvasc Res. 2017;114:114–28.
22. Crabtree MJ, Smith CL, Lam G, Goligorsky MS, Gross SS. Ratio of 5,6,7,8-
tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines
glucose-elicited changes in NO vs. superoxide production by eNOS. Am J
Physiol Heart Circ Physiol. 2008;294:H1530–40.
23. Kar S, Kavdia M. Modeling of biopterin-dependent pathways of eNOS for
nitric oxide and superoxide production. Free Radic Biol Med. 2011;51:1411–
27.
24. Kar S, Bhandar B, Kavdia M. Impact of SOD in eNOS uncoupling: a two-
edged sword between hydrogen peroxide and peroxynitrite. Free Radic Res.
2012;46:1496–513.
25. Bergstrom A, Staalso JM, Romner B, Olsen NV. Impaired endothelial function
after aneurysmal subarachnoid haemorrhage correlates with arginine:
asymmetric dimethylarginine ratio. Br J Anaesth. 2014;112:311–8.
26. Bonetti PO, Pumper GM, Higano ST, Holmes DR, Kuvin JT, Lerman A.
Noninvasive identification of patients with early coronary atherosclerosis by
assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44:2137–
41.
27. Mygind ND, Michelsen MM, Pena A, et al. Coronary microvascular function
and cardiovascular risk factors in women with angina pectoris and no
obstructive coronary artery disease: the iPOWER study. J Am Heart Assoc.
2016;5:e003064.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Ekeloef et al. BMC Anesthesiology           (2020) 20:67 Page 9 of 9
